Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Novavax (NVAX) Files Requesting Provisional Approval of its COVID-19 Vaccine in Australia
October 29, 2021 7:15 AM EDTNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA) for provisional approval of its COVID-19 vaccine candidate. The company's application to the TGA marks the first complete application for provisional approval of a protein-based COVID-19 vaccine in Australia.
"This submission brings Novavax significantly closer to delivering doses of the first protein-based COVID-19 vaccine to Australia and, along with this week's filing for... More
Novavax (NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine
October 27, 2021 8:59 AM EDTNovavax (NASDAQ: NVAX) Climbs 13% After Filing For UK Authorization of its COVID-19 Vaccine
... More